Evidence map›Paper›PMID 34926781›Full record

ArticleOne health (Amsterdam, Netherlands)2021

Development and implementation of National External Quality Assurance Programs in a One Health approach: The Armenian experience.

Julius Manjengwa, Arsen Zakaryan, Arnaud Orelle, Vivian Fensham, Arihanta Razafindranovonar, Naira Aleksanyan, Nune Kotsinyan, Hrant Danielyan, Pertsh Tumanyan, Zaruhi Davtyan and 2 more

Open access · goldAbstract read
In one paragraph

Article in One health (Amsterdam, Netherlands), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Julius ManjengwaIntegrated Quality Laboratory Services (IQLS), Lyon, France.
Arsen ZakaryanIntegrated Quality Laboratory Services (IQLS), Lyon, France.
Arnaud OrelleIntegrated Quality Laboratory Services (IQLS), Lyon, France.
Vivian FenshamIntegrated Quality Laboratory Services (IQLS), Lyon, France.
Arihanta RazafindranovonarEpiconcept IO, Armenia.
Naira AleksanyanNational Centre for Disease Control and Prevention, SNCO, Yerevan, Armenia.
Nune KotsinyanNational Centre for Disease Control and Prevention, SNCO, Yerevan, Armenia.
Hrant DanielyanArmenian Veterinary Reference Laboratory for Especially Dangerous Pathogens, Yerevan, Armenia.
Pertsh TumanyanArmenian Veterinary Reference Laboratory for Especially Dangerous Pathogens, Yerevan, Armenia.
Zaruhi DavtyanIntegrated Quality Laboratory Services (IQLS), Lyon, France.
Obert KachuwaireIntegrated Quality Laboratory Services (IQLS), Lyon, France.
Antoine PiersonIntegrated Quality Laboratory Services (IQLS), Lyon, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionEarly warning and objective evidence of systematic errors in laboratory diagnosis ensures evidence based corrective and preventive actions that instill patient safety and confidence. External quality assessment contributes significantly to the above as an essential component of laboratory quality assurance. However, implementation of External Quality Assessment in resource-limited settings is challenged by high costs of enrolling in international schemes. To ensure sustainability, a National External Quality Assessment Program in Armenia was developed using a One Health approach.

methodsThrough engagement of stakeholders from Ministry of Health and Department of Agriculture under Ministry of Economy the government of Armenia started the implementation of the Armenia Laboratory External Quality Assessment (ALEQA) program. Policies and procedures were defined, a web interface for return of results and feedback reporting was created. A training was offered for characterization of simulated samples for bacterial pathogens. Following a pilot survey, the program was successfully scaled up, with later addition of a Brucella serology discipline.

resultsThe return rate of results was 100% for all surveys. There was an improvement in the performance of the laboratories from the 2015 to the 2019 surveys. The bacterial pathogens EQA survey's, was interrupted between 2017 and 2019. The Brucella Serology survey showed 77% of the 26 participating laboratories had satisfactory performance.

conclusionThis is one of the few National EQA Programs that have embraced the One Health approach to improve reach of EQA Programs in resource-limited settings in both human and veterinary laboratories.

Indexed as

Bacterial pathogensBrucellosisExternal quality assessmentOne HealthQuality assuranceQuality control

Identifiers

PMID34926781
PMCPMC8648803
OpenAlexW3215466509

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.